203 related articles for article (PubMed ID: 36548081)
1. The UBE2C/CDH1/DEPTOR axis is an oncogene and tumor suppressor cascade in lung cancer cells.
Zhang S; You X; Zheng Y; Shen Y; Xiong X; Sun Y
J Clin Invest; 2023 Feb; 133(4):. PubMed ID: 36548081
[TBL] [Abstract][Full Text] [Related]
2. Ubiquitin-conjugating enzyme E2C: a potential cancer biomarker.
Xie C; Powell C; Yao M; Wu J; Dong Q
Int J Biochem Cell Biol; 2014 Feb; 47():113-7. PubMed ID: 24361302
[TBL] [Abstract][Full Text] [Related]
3. Ubiquitin-conjugating enzyme E2C regulates apoptosis-dependent tumor progression of non-small cell lung cancer via ERK pathway.
Zhang Z; Liu P; Wang J; Gong T; Zhang F; Ma J; Han N
Med Oncol; 2015 May; 32(5):149. PubMed ID: 25832867
[TBL] [Abstract][Full Text] [Related]
4. UBE2C, Directly Targeted by miR-548e-5p, Increases the Cellular Growth and Invasive Abilities of Cancer Cells Interacting with the EMT Marker Protein Zinc Finger E-box Binding Homeobox 1/2 in NSCLC.
Jin D; Guo J; Wu Y; Du J; Wang X; An J; Hu B; Kong L; Di W; Wang W
Theranostics; 2019; 9(7):2036-2055. PubMed ID: 31037155
[No Abstract] [Full Text] [Related]
5. The UBE2F-CRL5
Chang Y; Chen Q; Li H; Xu J; Tan M; Xiong X; Sun Y
Dev Cell; 2024 May; 59(10):1317-1332.e5. PubMed ID: 38574733
[TBL] [Abstract][Full Text] [Related]
6. Overexpressed lncRNA FTX promotes the cell viability, proliferation, migration and invasion of renal cell carcinoma via FTX/miR‑4429/UBE2C axis.
Chen Z; Zhang M; Lu Y; Ding T; Liu Z; Liu Y; Zhou Z; Wang L
Oncol Rep; 2022 Sep; 48(3):. PubMed ID: 35866591
[TBL] [Abstract][Full Text] [Related]
7. Inactivation of SAG/RBX2 E3 ubiquitin ligase suppresses KrasG12D-driven lung tumorigenesis.
Li H; Tan M; Jia L; Wei D; Zhao Y; Chen G; Xu J; Zhao L; Thomas D; Beer DG; Sun Y
J Clin Invest; 2014 Feb; 124(2):835-46. PubMed ID: 24430184
[TBL] [Abstract][Full Text] [Related]
8. Silencing ubiquitin-conjugating enzyme 2C inhibits proliferation and epithelial-mesenchymal transition in pancreatic ductal adenocarcinoma.
Wang X; Yin L; Yang L; Zheng Y; Liu S; Yang J; Cui H; Wang H
FEBS J; 2019 Dec; 286(24):4889-4909. PubMed ID: 31715067
[TBL] [Abstract][Full Text] [Related]
9. Depletion of SAG/RBX2 E3 ubiquitin ligase suppresses prostate tumorigenesis via inactivation of the PI3K/AKT/mTOR axis.
Tan M; Xu J; Siddiqui J; Feng F; Sun Y
Mol Cancer; 2016 Dec; 15(1):81. PubMed ID: 27955654
[TBL] [Abstract][Full Text] [Related]
10. Effects of ubiquitin-conjugating enzyme 2C on invasion, proliferation and cell cycling of lung cancer cells.
Tang XK; Wang KJ; Tang YK; Chen L
Asian Pac J Cancer Prev; 2014; 15(7):3005-9. PubMed ID: 24815438
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-196a post-transcriptionally upregulates the UBE2C proto-oncogene and promotes cell proliferation in breast cancer.
Han Q; Zhou C; Liu F; Xu G; Zheng R; Zhang X
Oncol Rep; 2015 Aug; 34(2):877-83. PubMed ID: 26062455
[TBL] [Abstract][Full Text] [Related]
12. Involvement of ubiquitin-conjugating enzyme E2C in proliferation and invasion of prostate carcinoma cells.
Shuliang S; Lei C; Guangwu J; Changjie L
Oncol Res; 2013; 21(3):121-7. PubMed ID: 24512726
[TBL] [Abstract][Full Text] [Related]
13. UBE2C-mediated Autophagy Inhibition via Ubiquitination of SIRT1 Contributes to Endometrial Cancer Progression.
Zhao R; Liu Y; Wang Z; Zhang J; Zhang W; Zhou X; Tsedendorj S; Enkhtur A; Feng D; Wang H
Mol Cancer Res; 2023 Jun; 21(6):564-577. PubMed ID: 36930831
[TBL] [Abstract][Full Text] [Related]
14. The miR 495-UBE2C-ABCG2/ERCC1 axis reverses cisplatin resistance by downregulating drug resistance genes in cisplatin-resistant non-small cell lung cancer cells.
Guo J; Jin D; Wu Y; Yang L; Du J; Gong K; Chen W; Dai J; Miao S; Xi S
EBioMedicine; 2018 Sep; 35():204-221. PubMed ID: 30146342
[TBL] [Abstract][Full Text] [Related]
15. Ceramide synthase 6 antisense RNA 1 contributes to the progression of breast cancer by sponging miR-16-5p to upregulate ubiquitin-conjugating enzyme E2C.
Pan W; Chen KJ; Huang YC
Anticancer Drugs; 2022 Oct; 33(9):913-922. PubMed ID: 36136991
[TBL] [Abstract][Full Text] [Related]
16. Anticancer effect of icaritin on prostate cancer via regulating miR-381-3p and its target gene UBE2C.
Hu J; Wu X; Yang C; Rashid K; Ma C; Hu M; Ding Q; Jiang H
Cancer Med; 2019 Dec; 8(18):7833-7845. PubMed ID: 31646760
[TBL] [Abstract][Full Text] [Related]
17. Neddylation E2 UBE2F Promotes the Survival of Lung Cancer Cells by Activating CRL5 to Degrade NOXA via the K11 Linkage.
Zhou W; Xu J; Li H; Xu M; Chen ZJ; Wei W; Pan Z; Sun Y
Clin Cancer Res; 2017 Feb; 23(4):1104-1116. PubMed ID: 27591266
[No Abstract] [Full Text] [Related]
18. Ubiquitin-conjugating enzyme UBE2C is highly expressed in breast microcalcification lesions.
Chou CP; Huang NC; Jhuang SJ; Pan HB; Peng NJ; Cheng JT; Chen CF; Chen JJ; Chang TH
PLoS One; 2014; 9(4):e93934. PubMed ID: 24699941
[TBL] [Abstract][Full Text] [Related]
19. The clinicopathological significance of ubiquitin-conjugating enzyme E2C, leucine-rich repeated-containing G protein-coupled receptor, WW domain-containing oxidoreductase, and vasculogenic mimicry in invasive breast carcinoma.
Shen R; Wu T; Huang P; Shao Q; Chen M
Medicine (Baltimore); 2019 Apr; 98(16):e15232. PubMed ID: 31008954
[TBL] [Abstract][Full Text] [Related]
20. Forkhead Box M1 positively regulates UBE2C and protects glioma cells from autophagic death.
Guo L; Ding Z; Huang N; Huang Z; Zhang N; Xia Z
Cell Cycle; 2017 Sep; 16(18):1705-1718. PubMed ID: 28767320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]